Coloplast surpasses guidance and sets out to launch share buyback program

Coloplast's Q1 fiscal report shows better overall results than what analysts expected. The firm also announces its plans to launch a share buyback program worth DKK 500m.
Photo: Coloplast / PR
Photo: Coloplast / PR
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

Tuesday morning Danish medtech firm Coloplast presented its Q1 report for the staggered fiscal year 2020/2021, which contained some surprises compared with what analysts had expected.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading